Loading organizations...

§ Private Profile · Toronto, Canada
Surgical robotics for every operating room
Key people at Revolve Surgical.
Revolve Surgical was founded in 2019 by Peter Francis (Founder) and Alex Gordon (Founder) and Matthew Kang (Founder).
Revolve is building the world’s only surgical robot designed for every operating room. Its simple yet powerful design makes it the only robot that can service the 1M+ abdominal surgeries performed outside of hospitals in the US every year.
Key people at Revolve Surgical.
Revolve Surgical was founded in 2019 by Peter Francis (Founder) and Alex Gordon (Founder) and Matthew Kang (Founder).
Revolve Surgical is a Canadian medical robotics company dedicated to making robotic surgery accessible and affordable for every operating room worldwide. Their mission is to raise the standard of care globally by providing a surgical robot designed to serve not only large hospitals but also independent outpatient centers and public healthcare systems. Revolve’s platform offers ergonomic, efficient, and modular robotic tools that reduce surgeon strain while enhancing control and vision during minimally invasive procedures. This hybrid manual-robotic system aims to democratize robotic surgery, which currently remains out of reach for approximately 97% of patients globally, by offering a cost-effective alternative with comparable pricing to laparoscopy[2][5].
Founded in 2019 by Alex Gordon, Peter Francis, and Matthew Kang, Revolve Surgical emerged from graduate research at SickKids hospital’s surgical robotics lab in Toronto. The founders, with backgrounds in mechanical, biomedical, and mechatronics engineering, identified the limitations of existing robotic surgery systems—particularly their inaccessibility in public healthcare due to high cost and complexity. Motivated to reimagine surgical robotics from the ground up, they developed a platform that eliminates teleoperation, allowing surgeons to retain direct control while benefiting from robotic precision and ergonomics. Early traction included clinical research and development leading to a simple, scalable robotic system ready for diverse healthcare settings[2][5].
Revolve Surgical is riding the global trend toward minimally invasive surgery and the increasing adoption of robotic assistance to improve surgical outcomes. The timing is critical as healthcare systems seek cost-effective, scalable solutions to expand access to advanced surgical care beyond major hospitals. Market forces such as rising demand for outpatient procedures, surgeon ergonomics, and value-based care models favor Revolve’s hybrid manual-robotic approach. By targeting the 97% of surgeries still performed manually, Revolve is positioned to influence the broader surgical robotics ecosystem by democratizing technology that was previously exclusive to high-resource settings[2][3][5].
Looking ahead, Revolve Surgical is poised to scale its platform across diverse healthcare environments, potentially disrupting the surgical robotics market by addressing affordability and accessibility challenges. Trends such as outpatient surgery growth, healthcare cost containment, and surgeon well-being will shape their trajectory. As the company advances clinical validation and commercial deployment, its influence may extend to redefining standards of care globally, making robotic surgery a routine option for a broader patient population. Revolve’s commitment to simplicity and scalability ties back to its founding vision of equitable surgical care for all operating rooms[2][5].